Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of IFI44L mRNA | affects cotreatment|increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of IFI44L mRNA | increases expression | 19619570
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in increased expression of IFI44L mRNA | affects cotreatment|increases expression | 17404688
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in increased expression of IFI44L mRNA | affects cotreatment|increases expression | 17404688
|
D013629 |
Tamoxifen |
Tamoxifen results in increased expression of IFI44L mRNA | increases expression | 19155303
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of IFI44L mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of IFI44L mRNA | affects cotreatment|increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of IFI44L mRNA | decreases expression | 19619570
|
D015215 |
Zidovudine |
[Zidovudine co-treated with IFNA1 protein] results in increased expression of IFI44L mRNA | affects cotreatment|increases expression | 20370541
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
5.07 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.31 | 15322242 14514962 11752688 |
MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
5.24 | 9612607 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.16 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.84 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.25 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.37 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.95 | 15746008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.86 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.68 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.97 | 17289903 16675129 12948864 14630087 19861407 17261762 18497071 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.97 | 17614352 15562024 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.97 | 19155303 16273361 19103187 19059307 20135344 21138602 19221464 19289846 19115204 19288272 19189210 20065188 15668708 19487384 19011961 20005174 19142967 17049068 19084267 19200415 19189212 18984771 18855134 17440819 17893378 21152245 16202921 17242785 18815881 17261762 11161223 19244106 20544844 16818667 18351453 20859285 15565566 16873071 18629630 19066611 18425577 18821012 18997820 20390343 19410462 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.97 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.93 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.92 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
3.10 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
3.10 | 16924424 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.92 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.52 | 16120746 18670907 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
2.98 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.45 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.21 | 12621046 15340226 15668235 8697196 16354765 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 20055451 15322242 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.78 | 19031437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
9.81 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
9.81 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.91 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.60 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
9.01 | 11462148 |
MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
9.01 | 15040536 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.70 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.42 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
10.46 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
10.46 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
8.04 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
8.04 | 19155303 17893378 16202921 20544844 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
9.96 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.96 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
9.19 | 19224547 14986274 |
MESH:D005234 |
Fatty Liver |
|
Zidovudine |
9.19 | 18299183 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.41 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.87 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.99 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.64 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.36 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.12 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.47 | 11294989 10048152 |
MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
5.06 | 12579204 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.66 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.31 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.55 | 15709030 |
MESH:D015658 |
HIV Infections |
|
Zidovudine |
3.63 | 11698656 11141242 20032539 17358032 11363243 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
6.27 | 17440010 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.27 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.57 | 8697196 16354765 15340226 18606429 16959395 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
2.00 | 18670907 18850075 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.82 | 15869954 |
MESH:D007249 |
Inflammation |
|
Progesterone |
9.16 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
9.16 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
9.16 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.16 | 16393666 16627594 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.66 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.74 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
14.12 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
14.12 | 18625569 |
MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
14.12 | 12579204 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
4.74 | 20370541 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.37 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.59 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.59 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.59 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
4.72 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.72 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.28 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
3.62 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.62 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
3.62 | 18800350 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.22 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
11.10 | 11408345 11807958 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
11.10 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
11.10 | 16827153 11731420 19196722 14580682 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
14.45 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
14.45 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.91 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.64 | 15990972 |
MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
6.36 | 17358032 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.27 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.52 | 16810080 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.65 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.60 | 19410462 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.52 | 19189210 19200415 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.19 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
10.77 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.77 | 14600291 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
5.14 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
5.14 | 16525653 17393432 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.77 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.94 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.65 | 11222880 11118676 11399792 11896295 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.21 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.10 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.10 | 15067354 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.22 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.94 | 18045962 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.17 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.81 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
12.46 | 16503802 15862959 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
12.46 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
2.48 | 17696246 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.42 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.21 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
2.45 | 8653321 17572228 16712894 |
MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
5.18 | 12579204 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.12 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.77 | 15886252 |